anti-CCR2 monoclonal antibody MLN1202
Term · Oncology and biomedicine · MLC-T-ONC-000594
A substance being studied as a treatment for atherosclerosis (a build-up of fat in the arteries). It is also being studied in the treatment of cancers that spread to the bone. Anti-CCR2 monoclonal antibody MLN1202 binds to a protein called CCR2, which is found on the surface of certain bone cells, white blood cells, and cancer cells. Anti-CCR2 monoclonal antibody MLN1202 blocks the action of a substance that is involved in keeping healthy bone mass. It may help keep the cancer cells from spreading to and growing in the bone. It is a type of monoclonal antibody. Also called MLN1202.
| Identifier | MLC-T-ONC-000594 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | MLN1202 |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000594",
"term": "anti-CCR2 monoclonal antibody MLN1202",
"field": "Oncology and biomedicine",
"definition": "A substance being studied as a treatment for atherosclerosis (a build-up of fat in the arteries). It is also being studied in the treatment of cancers that spread to the bone. Anti-CCR2 monoclonal antibody MLN1202 binds to a protein called CCR2, which is found on the surface of certain bone cells, white blood cells, and cancer cells. Anti-CCR2 monoclonal antibody MLN1202 blocks the action of a substance that is involved in keeping healthy bone mass. It may help keep the cancer cells from spreading to and growing in the bone. It is a type of monoclonal antibody. Also called MLN1202.",
"synonyms": [
"MLN1202"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/anti-ccr2-monoclonal-antibody-mln1202/"
}
Record 1,283 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.